Auto
|
Updated on 06 Nov 2025, 08:39 am
Reviewed By
Satyam Jha | Whalesbook News Team
▶
Hyundai Motor India is preparing for a significant push to regain its coveted second position in the competitive Indian passenger vehicle market. The company has laid out an ambitious vision, backed by a substantial investment of ₹45,000 crore planned by fiscal year 2030. This investment will fuel the introduction of 26 new products, encompassing a range of electric and hybrid vehicles, to cater to evolving market demands.
Tarun Garg, the current Whole-Time Director and COO who will take over as Managing Director and CEO from January 1, 2026, stated that the company's growth will be competitive and responsible, prioritizing fundamentals over sheer volume. He highlighted the importance of maintaining equilibrium between domestic and export markets, and balancing growth with responsibility.
Hyundai aims to leverage new models, enhanced production capacity, and a broader offering of electric and hybrid vehicles to reclaim the No. 2 market share position, which has recently seen challenges from rivals like Mahindra and Tata Motors. The automaker has already launched the all-new Hyundai Venue and Venue N Line, with the compact SUV now being manufactured exclusively in India for global markets, reinforcing its 'Make in India for the World' initiative. The compact SUV segment, particularly, has seen robust demand following GST reforms that benefit vehicles under 4 meters. Garg noted that SUVs continue to dominate sales, with customers increasingly upgrading to larger vehicles.
Impact This news is highly impactful for Hyundai Motor India's strategic direction and future market performance. The significant investment signals strong commitment to the Indian market, potentially boosting its stock value if the parent company's stock is considered or impacting investor sentiment towards the Indian auto sector overall. The focus on localization and new products could enhance its competitiveness against domestic players, leading to increased market share and revenue. The "Make in India for the World" aspect also bolsters India's manufacturing reputation. Impact Rating: 7/10
Difficult Terms Explained: Localization: The process of designing, manufacturing, and sourcing components or products within the country where they will be sold, reducing reliance on imports. GST: Goods and Services Tax, a unified indirect tax system in India. SUV: Sport Utility Vehicle, a type of vehicle combining elements of road-going passenger cars with features from off-road vehicles such as raised ground clearance and four-wheel drive. Hatchback: A car body configuration with a rear door (hatch) that swings upward to provide access to the cargo area.
Auto
Ola Electric Reports Significant Revenue Drop but Auto Segment Turns Profitable
Auto
Mahindra & Mahindra Reports Strong Q2FY26 with Margin Growth and Robust EV and Farm Segment Performance
Auto
Ola Electric Reports 15% Net Loss Reduction in Q2 FY26, Automotive Segment Turns Profitable
Auto
Mahindra & Mahindra Sells RBL Bank Stake for ₹678 Crore, Realizing 62.5% Profit
Auto
Ola Electric Stock Declines Ahead of Q3 Results; Analysts Expect Narrower Losses
Auto
Mahindra & Mahindra Stock Rallies on Strong Q2 Earnings and RBL Bank Stake Sale
Energy
Vedanta Secures 500 MW Power Supply Pact with Tamil Nadu for Five Years
Economy
Indian Equity Markets Close Lower Amid Volatility and Profit Booking
Banking/Finance
Cholamandalam Investment Reports 20% Profit Growth in Q2FY26 Amid Rising NPAs
Economy
India Services Sector Growth Slows to 5-Month Low in October
Consumer Products
India's Consumer Sector Faces Sweeping Leadership Overhaul
Economy
India’s Richest Donate Record Rs 10,380 Crore in 2025, Education Top Priority
Healthcare/Biotech
Sun Pharma's US Innovative Drug Sales Surpass Generics for First Time
Healthcare/Biotech
Zydus Lifesciences Reports 39% Profit Growth in Q2 FY26, Plans ₹5,000 Crore Fundraising
Healthcare/Biotech
Abbott India Reports 16% Profit Jump on Strong Revenue and Margins
Healthcare/Biotech
Indoco Remedies Posts Improved Q2 Earnings, Stock Sees Gains
Healthcare/Biotech
Medi Assist Healthcare Profit Drops 61.6% Amidst Acquisition and Tech Investments
Healthcare/Biotech
Zydus Lifesciences' Beta-Thalassemia Drug Desidustat Receives USFDA Orphan Drug Designation
Mutual Funds
Domestic Funds Rapidly Closing Gap with Foreign Investors in Indian Markets
Mutual Funds
State Bank of India to Divest 6.3% Stake in SBI Funds Management via IPO
Mutual Funds
Indian Investors Turn to Direct Mutual Fund Plans in 2025 for Cost Savings and Enhanced Portfolio Control
Mutual Funds
Helios Mutual Fund Launches New India Small Cap Fund
Mutual Funds
Kotak Mahindra AMC Launches New Fund Focused on India's Rural Growth Opportunities
Mutual Funds
Equitree Capital Advisors Surpasses ₹1,000 Crore in Assets Under Management